Lonafarnib-Based Regimens Look Promising for Patients With C

Statistically significant responses were observed in patients with chronic hepatitis delta virus treated with lonafarnib-based regimens.

Related Keywords

Ohad Etzion , Department Of Gastroenterology , Liver Diseases At Soroka University Medical Center , Liver Diseases , Soroka University Medical Center ,